Merus to Present at Citi’s 2025 Virtual Oncology Leadership Summit
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) --…
Kia to Present Global EV Leadership Strategy and Key Models at 2025 Kia EV Day
Kia to announce expanded global EV leadership strategy at 2025 Kia EV…
Parker Scheduled to Present at Barclays Industrial Select Conference on February 19 at 11:00 a.m. Eastern Time
CLEVELAND, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH),…
The Kraft Heinz Company to Present at 2025 CAGNY Conference on Feb. 18, 2025
PITTSBURGH & CHICAGO--(BUSINESS WIRE)--The Kraft Heinz Company (Nasdaq: KHC) (“Kraft Heinz”) will…
Revolo to Present at the 2025 AAAAI / WAO Joint Congress
February 10, 2025 12:00 ET | Source: Revolo Biotherapeutics GAITHERSBURG, Md. and…
Red Cat CEO Jeff Thompson to Present at TD Cowens 46th Annual Aerospace & Defense Conference
February 04, 2025 14:59 ET | Source: Red Cat Holdings, Inc. SAN…
Praxis Precision Medicines to Present at Two February Investor Conferences
BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:…
XORTX to Present at Microcap Conference
January 29, 2025 07:00 ET | Source: XORTX Therapeutics Inc. CALGARY, Alberta,…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…